Skip to content

Clinical trials

Phase 4 Hyperkalemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperkalemia Phase: Phase 4 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20131
20141
20161
20171
20182
20194
20201
20214
20224
20231
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status5
Terminated4
Not yet recruiting2
Recruiting1
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Baylor Research Institute1
Comprehensive Research Associates1
Duke University1
Hospital de Messejana Dr. Carlos Alberto Studart Gomes1
Leiden University Medical Center1
Maisonneuve-Rosemont Hospital1
NYU Langone Health1
Nantes University Hospital1
National Heart Foundation of Bangladesh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperkalemia27
Renal Insufficiency, Chronic8
Hypokalemia3
Albuminuria2
Diabetic Nephropathies2
Hypertension2
Insulin Resistance2
Kidney Failure, Chronic2
Arrhythmias, Cardiac1
Ascites1

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.